Bio-Convert A/S (“Bio-Convert”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting Nordic and U.S.

Introduction Older people in care homes are at increased risk of medication errors and adverse drug events. The effect of formulation on administration errors is not known, that is whether the ...

(RTTNews) - Clearmind Medicine Inc. (CMND), Wednesday announced ... to develop a novel intranasal formulation for its psychedelic-based treatment applications. Under the partnership, the companies ...

In the quest for enhanced male performance and vitality, men often seek safe and effective solutions that can provide ...

In the vast realm of traditional Chinese medicine (TCM), there are countless formulations that have stood the test of time, proving their efficacy and value across centuries. One such formulation ...

One of the great things about equity markets is that you don't need a fortune to get started. Though strong companies that ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

The new formulation was approved by the USDA in 2024 and provides a smaller size dose and with single nostril administration. 1 The new formulation is indicated for dogs as early as 3 weeks of age, ...

The Iowa Board of Regents has selected six outstanding University of Iowa faculty members to be honored for their ...

“Turmeric is best known for its anti-inflammatory properties,” says Dana Cohen, M.D., functional medicine physician and ...

Hua Medicine Announces 2024 Annual Results - HuaTangNing completed its first full year for reimbursement under the National Rei ...

In today’s fast-paced world, many individuals grapple with nerve discomfort and related conditions that can severely affect their quality of life. As the interest in holistic and natural remedies ...